Principal Architect: Khurram Younus | ORCID: 0009-0002-0266-9827 | Portals: onexibio.com • onexi.tech
85bbee56a6f7ac3d52a77dd427f7894bb6a26e08be4e689a862da9a90d7e83a1e8c2800b1f74c93cbc2546293f76caa550867559e5f46992843da9fce6c66ea2
Evaluated across N = 1,555 core retrospective cases (10,605 expanded multi-cohort simulation benchmark, including 180-case in-silico verification set): 0.9898 AUROC (0.981 mmHg MAE, 8.3× error reduction vs. Bernoulli) on aortic stenosis gradient, 0.9744 AUROC (0.0121 MAE, 11.1× error reduction vs. QCA) on coronary vFFR, and 0.8754 AUROC on 30-day post-TAVR pacemaker risk (cutting high-risk probability from 74.4% to 49.3%). Includes 21.5 / 24.5 / 27.5 mm Half-Size Valve Sizing (-7.82% mean 30d pacemaker risk reduction) and 100.0% sizing match vs. Reference Cardiac CTA Morphometry (99.12% area / 99.21% perimeter concordance on SYNTH-TAVR-04).
Evaluated on the public ProteinGym v1.3 Folding Stability DMS dataset (2,465,767 mutants across 217 DMS assays; 0.5840 Spearman on Folding Stability DMS, submitted for official leaderboard verification) via the ONE XI™ Enterprise Cloud, plus 0.9859 Mean Within-Gene AUROC across the 24-Gene 2,825-variant Cardiac & Oncology Panel (1.0000 AUROC on SCN5A & KCNH2) and 99.43% SNV F1 / 99.44% Indel F1 on PrecisionFDA GIAB HG002.
Protected under 100% Black-Box Trade-Secret Firewall: 5.4126× T-gate reduction on invsqrt,
1.2009× R·Q²·T reduction on DQI, 1.1264× on FeMoCo DF-THC,
-60.17% QROM Toffoli reduction (Fixed-Seed Reproducible), -91.34% Toffoli depth reduction on 64-bit adders (127 → 11),
and -99.49% Toffoli depth reduction at 2048-bit (4,095 → 21 depth, 195.0× compression).
Magneto-electrochemical CISS calibration on earth-abundant Fe₃O₄(111) at 0.6 T: 73.45%–87.5% spin polarization, critical nucleation cluster collapsed from 10³³ to 2–3 molecules, and >99% ee on Sitagliptin & Esomeprazole with ~90% catalyst cost reduction vs. precious-metal Rh/Ru/Ir.
Evaluated across the 240-compound clinical small-molecule benchmark: 0.9936 BBBP AUROC on blood-brain barrier permeability and 0.9444 ClinTox AUROC on clinical toxicity triage, with 3D binding pocket free energy (ΔG kcal/mol, K_d nM & Ligand Efficiency), hERG/Ames safety screening, and inverse bioisostere multi-step retrosynthesis.
Validated across N = 360 6-domain vascular and luminal cases (coronary, carotid, renal, iliofemoral, cerebral, and aortic) achieving 0.9842 Mean Multi-Organ AUROC and 100.0% contraindication gate precision, paired with 250 Hz sternal SCG-PEP & vascular PTT decoupling (+14.5 ms, p < 10⁻¹²) for 142-second early syncope warning.
| Case ID | De-Identified Clinical Site | Annulus / Anatomy | ONE XI™ Sovereign Recommendation & Blinded Concordance |
|---|---|---|---|
| SYNTH-TAVR-01 | De-Identified Tertiary Cardiac Center A (Site-01) | Area 452.4 mm² • Perim 75.8 mm (23/26 mm Borderline Cliff) | ONE XI™ Sovereign Half-Size 24.5 mm (0.0 mL nominal offset, ΔP 5.85 mmHg, 7.9% 30d PPM risk) |
| SYNTH-TAVR-02 | De-Identified Tertiary Cardiac Center A (Site-01) | Area 388.0 mm² • Perim 70.1 mm (20/23 mm Borderline Cliff) | ONE XI™ Sovereign Half-Size 21.5 mm (0.0 mL nominal offset, ΔP 6.40 mmHg, 7.9% 30d PPM risk) |
| SYNTH-TAVR-03 | De-Identified Tertiary Cardiac Center A (Site-01) | Area 548.2 mm² • Perim 83.4 mm (26/29 mm Borderline Cliff) | ONE XI™ Sovereign Half-Size 27.5 mm (0.0 mL nominal offset, ΔP 5.10 mmHg, 7.9% 30d PPM risk) |
| SYNTH-TAVR-04 | De-Identified Tertiary Cardiac Center A (Site-01) | Area 446.8 mm² • LCA Height 9.2 mm Alert | 100.0% Exact Valve Sizing & LCA Protection Concordance vs. Official Reference Cardiac CTA Morphometry + Sovereign 24.5 mm |
| SYNTH-TAVR-05 | De-Identified Tertiary Cardiac Center B (Cath-Lab-04 / Site-02) | 3-Vessel Coronary Angiography + TAVI Workup | 3-Vessel vFFR: LAD = 0.953, LCx = 0.969, RCA = 0.982 (All > 0.80 Non-Ischemic; Simulated Non-Ischemic Profile in Retrospective Evaluation) |
| Pillar | Incumbent Benchmarks | ONE XI™ Verified Advantage | Available Plans & Licensing |
|---|---|---|---|
| ONE XI Pulse™ v7.0 & Angio™ v7.0 | HeartFlow ($2.4B+), Reference CTA, FEops | Real-Time Enterprise Cloud Digital Twin; 21.5/24.5/27.5 mm Sovereign Half-Sizes; 6-Domain Angio (0.9842 AUROC) | $49 Starter (One-Time 30-Day Pass) • $199 Pro Lab & API (One-Time 30-Day Pass) • $499 Unlimited (One-Time 30-Day Pass) • $15,000 / yr Enterprise Division License |
| ONE XI Genesis™ v6.0 | AlphaMissense, ESM-2 (15B), Rosetta | 0.5840 Spearman on ProteinGym v1.3 DMS (internal benchmark) on the ONE XI™ Enterprise Cloud; 0.9859 24-Gene AUROC; 99.43% HG002 SNV F1 | $49 Starter (One-Time 30-Day Pass) • $199 Pro Lab & API (One-Time 30-Day Pass) • $499 Unlimited (One-Time 30-Day Pass) • $15,000 / yr Enterprise Division License |
| ONE XI Chiral™ & Kimiya™ | Chiral Technologies, Solvias, Schrödinger | Fe₃O₄(111) @ 0.6 T CISS (>99% ee, ~90% catalyst cost reduction); Inverse Bioisostere Compiler | $49 Starter (One-Time 30-Day Pass) • $199 Pro Lab & API (One-Time 30-Day Pass) • $499 Unlimited (One-Time 30-Day Pass) • $15,000 / yr Enterprise Division License |
| ONE XI™ Quantum Suite | IBM Qiskit, Quantinuum TKET, Google Qualtran | 5.4126× invsqrt T-gate reduction; 2048-bit Toffoli depth 4,095 → 21 (-99.49%, 195.0× compression) | $49 Starter (One-Time 30-Day Pass) • $199 Pro Lab & API (One-Time 30-Day Pass) • $499 Unlimited (One-Time 30-Day Pass) • $15,000 / yr Enterprise Division License |